Illicit Stimulant-Involved Mortality Rates Rapidly Rising in the United States
Stimulant mortality has been on the rise since 2010 with a doubling of the mortality rate every 4 years.
Stimulant mortality has been on the rise since 2010 with a doubling of the mortality rate every 4 years.
To clarify the potential side effects of THC exposure in older adults, investigators conducted a systematic review of RCTs reporting the safety and efficacy of various cannabinoid-based medicines in adults older than 50 years.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
Most PPAs in prescribers’ practices focused on rules and consequences of noncompliance instead of on a shared treatment plan.
While previous studies have looked at opioid use among youth, information is lacking on heroin and stimulant overdose rates. The researchers investigated trends in suspected nonfatal drug overdoses (all drugs, opioids, heroin, and stimulants) reported to emergency departments between 2016 and 2019
This study examines neural circuits and cell types that mediate the suppressive effect of GLP-1R agonists on cocaine-seeking behaviors.
Patients with cancer who receive intense smoking cessation treatment are compared with patients who receive standard treatment to analyze the intervention’s impact on the likelihood of quitting smoking.
With COVID-19 having truly disastrous effects, the study authors sought to uncover the toll of substance abuse during the pandemic.
For adults with methamphetamine use disorder, response is higher with receipt of extended-release injectable naltrexone plus oral extended-release bupropion versus placebo.
Researchers analyzed how substance use disorder affected the risk of hospitalization, complications and mortality among adult patients who were diagnosed with having a COVID-19 infection.